v3.26.1
Investment Securities
12 Months Ended
Dec. 31, 2025
Investment Securities  
Investment Securities

5. Investment Securities

The following represents the Company’s investment securities for the years ended December 31, 2025 and 2024:

Balance at December 31, 2025

Acquisition
Cost

Accretion /
(Amortization)

Unrealized
Gain / (Loss)

Estimated
Fair Value

Commercial paper

$

4,888

$

34

$

$

4,922

Corporate notes / bonds

24,063

96

2

24,161

Money market funds

5,287

5,287

U.S. govt. agencies

11,192

64

5

11,261

U.S. treasuries

4,881

11

(1)

4,891

Total investment securities

$

50,311

$

205

$

6

$

50,522

Balance at December 31, 2024

Acquisition
Cost

Accretion /
(Amortization)

Unrealized
Gain / (Loss)

Estimated
Fair Value

Commercial paper

$

10,130

$

254

$

3

$

10,387

Corporate notes / bonds

45,336

483

7

45,826

Money market funds

2,766

2,766

U.S. govt. agencies

1,441

31

(2)

1,470

U.S. treasuries

6,609

41

(1)

6,649

Total investment securities

$

66,282

$

809

$

7

$

67,098


Accretion / (amortization) refers to the discounts and premiums incurred on bonds and notes purchased and are included within interest income on our consolidated income statement.

Accrued interest receivable, related to the above investment securities, amounted to $314 and $504 for the years ended December 31, 2025 and 2024 and are included within Other Receivables on our consolidated balance sheets.

Contractual maturities of investment securities as of December 31, 2025 are as follows:

Acquisition
Cost

Estimated
Fair Value

Original maturities of 90 days or less

$

6,282

$

6,283

Original maturities of 91-365 days

44,029

44,239

Original maturities of 366+ days

-

-

Total investment securities

$

50,311

$

50,522